RACHEL GILLESPIE: Open Payments
NPI 1174892400 · HARRISONBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$26,374 in 145 payments from 13 companies in 2025. Trend: 2023 $2,101 · 2024 $7,655 · 2025 $26,374
Speaker / faculty: $21,713Food & beverage: $3,081Travel & lodging: $1,381Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 60 | $24,319 |
| ABBVIE INC. | 18 | $511 |
| UCB, Inc. | 16 | $362 |
| Novartis Pharmaceuticals Corporation | 13 | $282 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $271 |
| Regeneron Healthcare Solutions, Inc. | 7 | $223 |
| Lilly USA, LLC | 7 | $145 |
| E.R. Squibb & Sons, L.L.C. | 2 | $111 |
| GENZYME CORPORATION | 3 | $78 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
Products named: TREMFYA, SKYRIZI, Bimzelx, DUPIXENT, COSENTYX, ILUMYA, EBGLYSS, Sotyktu.
Industry payments across VA — which companies pay providers there.
